Cargando…
Updated Evaluation of Dupilumab in the Treatment of Asthma: Patient Selection and Reported Outcomes
Uncontrolled asthma continues to be a problem for many patients with moderate-to-severe allergic asthma. Dupilumab, which blocks the receptors for interleukin-4 and interleukin-13, has been effective in reducing asthma exacerbations, improving forced expiratory volume in one second (FEV(1)), and red...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061408/ https://www.ncbi.nlm.nih.gov/pubmed/32184610 http://dx.doi.org/10.2147/TCRM.S192392 |